Pavlovskaya, [b] Neil R. Thomas,* [a] Henryk Faas,* [b] and Thomas Meersmann* [b] Abstract: A new approach for hyperpolarized 129 Xe molecular sensors is explored using paramagnetic relaxation agents that can be deactivated upon chemical or enzymatic reaction with an analyte. Cryptophane encapsulated 129 Xe within the vicinity of the paramagnetic center experiences fast relaxation that, through chemical exchange of xenon atoms between cage and solvent pool, causes accelerated hyperpolarized 129 Xe signal decay in the dissolved phase. In this work, the relaxivity of Gadolinium III -DOTA on 129 Xe in the solvent was increased eightfold through tethering of the paramagnetic molecule to a cryptophane cage. This potent relaxation agent can be 'turned off' specifically for 129 Molecular imaging enables the in vivo detection of the spatial distribution of specific target molecules that serve as 'biomarkers' for organ physiology. Imaging of biomarkers allows for the early detection of disease, for better monitoring of treatment, and for drug development. Among the strategies to enable molecular MRI [1] the hyperpolarized (hp) 129 Xe biosensor concept pioneered by Pines, Wemmer, and co-workers [2] is a promising candidate due to xenon's non-toxicity, the simplicity of the corresponding NMR spectra, and its solubility in blood plasma and tissue.
[ [2a] for which biotin has a very high affinity. [8] and in vivo organ uptake of functionalized nanoparticles, [9] in vivo MRI usage in complex organisms such as vertebrates is generally limited by the achievable low spectral resolution. This is a limitation wherever chemical shift is required to distinguish between a binding (or cleaving) event and unspecific interaction (i.e. typically non-reacted sensors that are still present to a significant extent). A very promising advancement has been reported very recently that does not require high spectral resolution because the unspecific background was very small. HyperCEST enabled imaging of cell-surface glycans at nanomolar concentrations in live-cell bioreactors [5] . However, wherever the biosensor molecules interacting with biomarker molecules need to be distinguished from a significant amount of biosensors that have not been bound, cleaved, or otherwise reacted biomarker specifically, imaging will likely have to cope with small chemical shift differences between the two biosensor moieties. This proof-of-concept study presents a different approach for hp 129 Xe biosensors, sketched in Fig. 1b , using paramagnetic relaxation instead of the chemical shift. Paramagnetic relaxation causes rapid decay of the hp signal. Paramagnetic metal centers are therefore usually avoided for hp MRI probes, except for the generation of negative contrast through shortened T1, T2, or T2* times. [10] Note that upon submission of this manuscript, the authors learned that a paramagnetic relaxation based hp 129 Xe biosensor concept has also been reported by Wemmer, Pines, and co-workers [11] . Fig. 3A and Fig. 3B for comparison. The relaxivity of CrA-GdDOTA for 1 A 1 mM CrA-GdDOTA solution corresponds to a 129 Xe(sol) relaxation time of T1 = 2.4 s that is sufficiently short to affect the overall relaxation in vivo. Unlike HyperCEST, this effect does not require radiofrequency irradiation for saturation to accomplish depolarization. Rather, depolarization occurs as the consequence of the combined effect of relaxation in the bound phase (i.e. 129 Xe in the cage) followed by chemical exchange leads to the fast decay of the dissolved phase signal. To deactivate the depolarization, the relaxation agent will need to be 'turned off' through selective chemical or biochemical Fig. 3C . This value is still 2 times higher than that found for GdDOTA in Fig. 3A , most likely because of increased contact of 129 Xe(sol) with the unchelated paramagnetic metal ion (similarly effecting the 1 H relaxation in Fig. 3C ). In a control experiment the relaxivity of GdCl3 for 129 Xe in H2O/ACN solution (Fig 3D, pH = 7 ) was found to be R1/[Rx] = 0.0847 s -1 mM -1 , close to the value in Fig. 3C at pH = 0. Fig. 2 also shows the time behavior (i -iii) of the DOTA protonation and the associated change in relaxivity that took several days for completion. This time behavior was verified through HPLC and mass spectrometry (see Supporting Information). It demonstrates that the change in relaxivity was indeed caused by the separation of the Gd III center from the cryptophane cage and not by a pH dependence of the xenon inout exchange rate with the cryptophane cage, in agreement with previous literature studying pH effects. [15] Conclusions. The relaxation data generated in this study demonstrates a dramatic increase in relaxivity of a GdDOTA for 129 Xe when the complex is tethered to a cryptophane cage. This increase is the consequence of the prolonged duration of cage bound 129 Xe in close vicinity to the paramagnetic metal center.
The strong relaxation experienced by cage bound xenon is transferred through chemical exchange to the solvent phase 129 Xe. The dissolved phase 129 Xe signal decays at a rate that is the average of the relaxation rate in the cage and the relaxation rate in the solvent, scaled by the duration that the xenon atoms remain in the two respective phases. [18] Similarly, cleavable linkers between a paramagnetic group and cryptophane cage may provide a usable responsive hp 129 Xe relaxation agents. The molecular design of the hp 129 Xe depolarization based biosensors can be advanced through an increase in the number of captured xenon atoms, for example through the usage of multiple cryptophane cages or through capsides [19] that would also increase rotational correlation times. Both effects will likely increase the relaxivity of the activated state but not of the deactivated state. Finally, Gd III can be substituted by other paramagnetic groups with stronger relaxation properties such as Mn(II) nanoparticles.
[20]
Experimental Section
As described in detail in the Supporting Information, the model sensor CrA-GdDOTA was synthesized from a DOTA chelator, modified with a short linker, and cryptophanol. Cryptophanol was synthesized as previously reported by Bertault and co-workers, [7d] while the DOTA-linker was simply obtained by reacting an appropriately protected DO3A with a short bisamide linker with alpha-bromoacetyl as terminal. The cryptophanol was then reacted with the alpha-bromoacetyl group to form an ether. After deprotection of the DOTA carboxylic groups, the Gd III cation was successfully chelated, yielding the desired compound CrAGdDOTA.
All NMR relaxation measurements were obtained at a temperature of 293 K at 9.4 T field strength. Hp 129 Xe was produced through spin exchange optical pumping (SEOP) using a custom-built instrument described elsewhere. [21] Prior to hp 129 Xe delivery in each experiment the solution was purged with N2 for 2 min to ensure the removal of any residual O2. The hp gas mixture was then delivered under continuous flow SEOP conditions for 45 s at 40 ml/min into the relaxation agent containing solution. After flow stoppage, the dissolved phase hp 129 Xe T1 relaxation was measured through a sequence of 16 constant flip angle (12°) experiments. [22] A standard inversion recovery sequence was used to obtain the 1 H T1 relaxation of H2O.
